ReviewMolecules (Basel, Switzerland)2026
Circular RNAs Associated with Human Cytomegalovirus Infection.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Human cytomegalovirus (HCMV) can cause life-threatening diseases in immunocompromised individuals. Moreover, HCMV is the leading cause of virus-associated congenital infections. As one of the eight human herpesviruses, HCMV is particularly associated with a range of neurological impairments, including microcephaly, hearing loss, and developmental delays. Given its significant impact on early development, there is strong motivation to explore alternatives and complements to current antiviral therapies to better mitigate HCMV-associated diseases. Like other herpesviruses, HCMV establishes lifelong infections characterized by alternating latent and lytic phases, enabling the virus to evade immune clearance. These transitions are accompanied by substantial changes in viral and host gene expression, which influence cellular pathways and regulatory mechanisms. Circular RNAs (circRNAs) have recently been identified as products of the HCMV transcriptome and have attracted increasing attention due to their potential roles in infection and pathogenesis. This review focuses on elucidating the functions of HCMV-derived circRNAs, their interactions with both viral and host transcriptomes, and the methodologies used for their identification and analysis. Recent advances in this field have expanded our understanding of the HCMV transcriptome and its contribution to disease, highlighting circRNAs as potential candidates for future biomarker or therapeutic studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.